Navigation Links
Drug May Slow Early Prostate Cancer: Study
Date:1/24/2012

By Denise Mann
HealthDay Reporter

TUESDAY, Jan. 24 (HealthDay News) -- New research suggests that Avodart, a drug used to treat an enlarged prostate gland, may help slow the progression of early stage prostate cancer, reducing the need for aggressive treatment in some men.

Prostate cancer can grow and spread slowly, which is why some men are urged to engage in so-called watchful waiting when the cancer is first diagnosed. Avodart (dutasteride) may help such men feel comfortable with surveillance as opposed to radical treatment, the researchers noted.

"The concept of active surveillance is gaining traction in most parts of the world," said study author Dr. Neil E. Fleshner, head of the division of urology at the Princess Margaret Hospital in Toronto. Still, some men are uncomfortable with doing nothing in the face of a cancer diagnosis, he said. "By using this drug, we can improve the proportion of men who remain committed to the surveillance."

The findings are published online Jan. 25 in The Lancet.

According to the U.S. National Cancer Institute, one out of every six men in the United States will develop prostate cancer in his lifetime. But because many of those cancers are low-grade, most will die of something else.

Avodart belongs to a class of drugs called 5-alpha reductase inhibitors. These drugs work by interfering with the effects of certain male hormones on the prostate. In the three-year study, prostate cancer progressed in 38 percent of 144 men with early prostate cancer who were treated with Avodart and 48 percent of the 145 men who received a placebo.

Men seem less anxious about the cancer diagnosis when they are doing something more proactive, Fleshner said. "The drug augments active surveillance and avoids most of the side effects associated with surgery and radiation," he said. Prostate removal surgery and/or radiation can lead to impotence and incontinence, he said.

The medication does have side effects, however, including reversible breast enlargement and tenderness and some sexual dysfunction.

"We know that we are over-treating prostate cancer," said Dr. Louis Potters, chairman of radiation medicine at North Shore University Hospital and Long Island Jewish Medical Center in Manhasset, N.Y.

"In the U.S., patients have a tendency to hear the word 'cancer,' and want to treat it right away," he said. "In these men with early prostate cancer, we can now say, 'Let's put you on this medication, and see what happens over the next couple of months.'"

However, some experts have concerns about 5-alpha reductase inhibitors. The U.S. Food and Drug Administration recently issued a warning that men who take these drugs to treat enlarged prostate glands may be at increased risk for high-grade prostate cancer.

Dr. Ryan Terlecki, an assistant professor of urology at Wake Forest Baptist Medical Center in Winston-Salem, N.C., said this may dampen enthusiasm for use of the drug to treat cancer.

"The overall role that these medications will play for urologists will decrease," Terlecki said. Doctors will likely begin looking toward noninvasive and/or non-medical treatments such as the use of thermal heat to cope with some of the symptoms of prostate conditions, he added.

More information

Learn more about prostate cancer at the American Cancer Society.

SOURCES: Neil E. Fleshner, M.D., head, division of urology, Princess Margaret Hospital, Toronto; Louis Potters, M.D., chairman, radiation medicine, North Shore University Hospital and LIJ Medical Center, Manhasset, N.Y.; Ryan Terlecki, M.D., assistant professor, urology, Wake Forest University, Winston-Salem, N.C.; Jan. 25, 2012, The Lancet, online


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Rate of physician referrals nearly doubled
2. Small Stem Cell Study Claims Early Success in Treating Eye Disease
3. New test offers greater accuracy in early detection of colorectal cancer
4. JCI online early table of contents: Jan. 17, 2012
5. Is Continued Lip-Reading an Early Sign of Autism?
6. Tests Might Someday Help Spot Early Lung Cancer
7. Disruption of biological clocks causes neurodegeneration, early death
8. Early-stage breast cancer patients lack knowledge; may not receive treatment they prefer
9. Hopkins researchers find Google Flu Trends a powerful early warning system for emergency departments
10. JCI online early table of contents: Jan. 9, 2012
11. Researchers find malignancy-risk gene signature for early-stage non-small cell lung cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Drug May Slow Early Prostate Cancer: Study
(Date:5/28/2016)... Aliso Viejo, California (PRWEB) , ... May 28, 2016 , ... ... just need to drag and drop a preset onto their media," said Christina Austin ... from Pixel Film Studios, editors can quickly and easily add stylish color grades to ...
(Date:5/27/2016)... ... 27, 2016 , ... Southland Log Homes , designer and manufacturer of ... kits, which can be found on its website at SouthlandLogHomes.com. , The designs of ... they highlight the craftsmanship of timber post and beam construction. The result is ...
(Date:5/27/2016)... New York, NY (PRWEB) , ... May 27, 2016 , ... ... the factors of a stroke, which we as a society can control and change. ... a stroke occurs nearly every 40 seconds within the United States. Plus, with an ...
(Date:5/27/2016)... (PRWEB) , ... May 27, 2016 , ... Aimed at ... human interest stories, which come courtesy of leaders in the nursing and health care ... from leading advocates and associations—namely Abilene Christian University. , As the nursing industry ...
(Date:5/26/2016)... Hampshire (PRWEB) , ... May 26, 2016 , ... ... care products, has been honored with a 2016 When Work Works Award for its ... award, part of the national When Work Works project administered by the Families and ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... 2016 Amarantus BioScience Holdings, Inc. ... for Regenerative Medicine, Neurology and Orphan Diseases, today announced that President ... two upcoming investor conferences: SeeThru Equity MicroCap Conference ... New York City , NY When: Tuesday, ... MicroCap Conference   Where: Grand Hyatt Hotel, 109 East ...
(Date:5/26/2016)... , May 26, 2016 ... With Both Cost Savings and Overall Decreased ... (LSE: BTG), an international specialist healthcare company, has ... the 21st Annual Meeting of ISPOR (International Society ... of hepatocellular carcinoma (HCC) using yttrium-90 glass microspheres ...
(Date:5/25/2016)... 25, 2016 According to a ... (3D, 2D, 4D), by Therapeutic Area (Oncology, Cosmeceutical/Plastic Surgery), ... (Medical Device Manufacturers, Hospitals/ Clinics) - Forecast to 2021", ... Animation Market for the forecast period of 2016 to ... Million by 2021 from USD 117.3 Million in 2016, ...
Breaking Medicine Technology: